Figures & data
Figure 1. CT scan of a malignant pleural mesothelioma patient receiving tremelimumab. (A–D) Computer tomography (CT) scans were performed at baseline (A) and after the second (day 180, B), fourth (day 470, C), and seventh (day 630, D) dose of tremelimumab. The patient achieved a partial response (C and D) after initial disease progression was noted at the first (data not shown) and second assessments (B).
